Cerity Partners LLC Invests $1.49 Million in Sotera Health (NASDAQ:SHC)

Cerity Partners LLC acquired a new stake in Sotera Health (NASDAQ:SHC) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 89,159 shares of the company’s stock, valued at approximately $1,489,000.

Other hedge funds have also recently added to or reduced their stakes in the company. William Blair Investment Management LLC boosted its position in shares of Sotera Health by 0.6% during the second quarter. William Blair Investment Management LLC now owns 1,131,455 shares of the company’s stock worth $13,430,000 after purchasing an additional 6,707 shares in the last quarter. Clearline Capital LP bought a new position in shares of Sotera Health during the second quarter worth $1,707,000. First Pacific Advisors LP bought a new position in shares of Sotera Health during the second quarter worth $540,000. Darsana Capital Partners LP bought a new position in shares of Sotera Health during the second quarter worth $29,074,000. Finally, Bank of New York Mellon Corp boosted its position in shares of Sotera Health by 3.9% during the second quarter. Bank of New York Mellon Corp now owns 1,004,046 shares of the company’s stock worth $11,918,000 after purchasing an additional 37,681 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Insider Transactions at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the transaction, the director now directly owns 49,215,301 shares in the company, valued at $739,705,974.03. The trade was a 16.89 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 55.12% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on SHC shares. Barclays boosted their price objective on shares of Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research report on Tuesday, August 6th. Citigroup boosted their price objective on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a research report on Thursday, November 21st. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $16.50.

Sotera Health Stock Down 3.2 %

Shares of SHC stock opened at $12.83 on Wednesday. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.44. The firm’s fifty day moving average price is $15.10 and its two-hundred day moving average price is $14.07. The firm has a market capitalization of $3.63 billion, a P/E ratio of 51.32 and a beta of 1.96.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business had revenue of $285.47 million during the quarter, compared to analyst estimates of $278.64 million. During the same quarter in the previous year, the firm posted $0.18 earnings per share. The firm’s quarterly revenue was up 8.5% on a year-over-year basis. On average, equities analysts predict that Sotera Health will post 0.61 EPS for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.